关注
Helena Populo
Helena Populo
Postdoctoral fellow
在 ipatimup.pt 的电子邮件经过验证
标题
引用次数
引用次数
年份
The mTOR signalling pathway in human cancer
H Pópulo, JM Lopes, P Soares
International journal of molecular sciences 13 (2), 1886-1918, 2012
10452012
Frequency of TERT promoter mutations in human cancers
J Vinagre, A Almeida, H Pópulo, R Batista, J Lyra, V Pinto, R Coelho, ...
Nature communications 4 (1), 2185, 2013
10042013
Melanoma treatment in review
B Domingues, JM Lopes, P Soares, H Pópulo
ImmunoTargets and therapy, 35-49, 2018
7632018
Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration
A Ferreira-da-Silva, C Valacca, E Rios, H Pópulo, P Soares, ...
PloS one 10 (3), e0122308, 2015
2112015
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
J Vinagre, V Pinto, R Celestino, M Reis, H Pópulo, P Boaventura, M Melo, ...
Virchows Archiv 465, 119-133, 2014
1522014
TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation
H Pópulo, P Boaventura, J Vinagre, R Batista, A Mendes, R Caldas, ...
Journal of Investigative Dermatology 134 (8), 2251-2257, 2014
1462014
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma
A Faustino, JP Couto, H Populo, AS Rocha, F Pardal, ...
The Journal of Clinical Endocrinology & Metabolism 97 (7), E1139-E1149, 2012
942012
Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma
H Pópulo, P Soares, AS Rocha, P Silva, JM Lopes
Melanoma research 20 (2), 107-117, 2010
902010
Disruption of iron-sulphur cluster N2 from NADH: ubiquinone oxidoreductase by site-directed mutagenesis
M Duarte, H Pópulo, A Videira, T Friedrich, U Schulte
Biochemical Journal 364 (3), 833-839, 2002
612002
mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics
H Populo, P Soares, A Faustino, AS Rocha, P Silva, F Azevedo, JM Lopes
Pigment cell & melanoma research 24 (1), 254-257, 2011
592011
Insights into melanoma: targeting the mTOR pathway for therapeutics
H Pópulo, P Soares, JM Lopes
Expert opinion on therapeutic targets 16 (7), 689-705, 2012
552012
Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
H Pópulo, J Vinagre, JM Lopes, P Soares
British Journal of Ophthalmology 95 (5), 715-719, 2011
552011
Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
H Populo, R Caldas, JM Lopes, J Pardal, V Maximo, P Soares
Expert opinion on therapeutic targets 19 (6), 733-745, 2015
332015
Expression and clinical relevance of SOX9 in gastric cancer
P Mesquita, AF Freire, N Lopes, R Gomes, D Azevedo, R Barros, ...
Disease Markers 2019 (1), 8267021, 2019
222019
Inhibitory effects of antagonists of growth hormone-releasing hormone (GHRH) in thyroid cancer
H Pópulo, B Nunes, C Sampaio, R Batista, MT Pinto, TB Gaspar, ...
Hormones and Cancer 8, 314-324, 2017
192017
GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells
H Populo, S Tavares, A Faustino, JB Nunes, JM Lopes, P Soares
PeerJ 1, e104, 2013
192013
Melanocytic tumour in a black sheep never exposed to ultraviolet radiation
H Vala, H Pópulo, JR Mesquita, F Esteves, C Santos, P Soares, JM Lopes
Journal of comparative pathology 146 (2-3), 160-164, 2012
82012
Tendências do carcinoma espinocelular cutâneo no Hospital de Gaia (2004-20013)
MAC Campos, AF Massa, P Varela, A Moreira, A Sanches, H Pópulo, ...
Journal of the Portuguese Society of Dermatology and Venereology 76 (3), 279-286, 2018
62018
Combinatorial therapies to overcome BRAF/MEK inhibitors resistance in melanoma cells: an in vitro study
H Pópulo, B Domingues, C Sampaio, JM Lopes, P Soares
Journal of experimental pharmacology, 521-535, 2021
52021
RE: TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma
H Pópulo, JM Lopes, M Sobrinho-Simões, P Soares
Journal of the National Cancer Institute 107 (4), djv049, 2015
52015
系统目前无法执行此操作,请稍后再试。
文章 1–20